Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Rheumatoid arthritis databases in Finland.

T Sokka1

  • 1Vanderbilt University/ Rheumatology, 203 Oxford House, Nashville, TN 37232-4500, USA. tuulikki.sokka@vanderbilt.edu

Clinical and Experimental Rheumatology
|November 9, 2005
PubMed
Summary

Finnish rheumatoid arthritis (RA) studies track long-term outcomes. This review covers observations from the FIN-RACo trial and the Central Finland RA Database, highlighting decades of patient data.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Immunogenicity of subcutaneous TNF inhibitors and its clinical significance in real-life setting in patients with spondyloarthritis.

Rheumatology international·2021
Same author

Three out of four disease-modifying anti-rheumatic drug-naïve rheumatoid arthritis patients meet 28-joint Disease Activity Score remission at 12 months: results from the FIN-ERA cohort.

Scandinavian journal of rheumatology·2017
Same author

Drug survival on tumour necrosis factor inhibitors in patients with rheumatoid arthritis in Finland.

Scandinavian journal of rheumatology·2016
Same author

A nationwide cross-sectional overview of patients with rheumatoid arthritis followed in outpatient specialty clinics in Finland.

Scandinavian journal of rheumatology·2014
Same author

Long-term prednisone in doses of less than 5 mg/day for treatment of rheumatoid arthritis: personal experience over 25 years.

Clinical and experimental rheumatology·2011
Same author

Finalisation and validation of the rheumatoid arthritis impact of disease score, a patient-derived composite measure of impact of rheumatoid arthritis: a EULAR initiative.

Annals of the rheumatic diseases·2011

Area of Science:

  • Rheumatology
  • Epidemiology
  • Clinical Trials

Background:

  • Finland has a strong tradition of longitudinal studies on rheumatoid arthritis (RA) outcomes.
  • Previous studies focused on work disability and mortality in RA patients.
  • Longitudinal data collection is crucial for understanding RA's long-term impact.

Purpose of the Study:

  • To review long-term observations from the Finnish RA Combination Therapy Trial (FIN-RACo).
  • To describe the Central Finland RA Database for comprehensive RA patient data.
  • To synthesize findings from decades of RA research in Finland.

Main Methods:

  • Review of longitudinal observational data from the FIN-RACo trial (initially a 2-year randomized controlled trial).
  • Description of the Central Finland RA Database, capturing RA diagnoses since 1980.
  • Analysis of data from a large patient cohort in a defined geographical area.

Main Results:

  • Long-term follow-up data from FIN-RACo provides insights into RA progression and treatment outcomes.
  • The Central Finland RA Database offers a valuable resource for epidemiological research on RA.
  • Decades of Finnish RA studies contribute to understanding disease trajectories and patient impact.

Conclusions:

  • Longitudinal studies are essential for understanding the long-term prognosis of rheumatoid arthritis.
  • The FIN-RACo trial and Central Finland RA Database represent significant contributions to RA research.
  • Continued data collection and analysis are vital for improving RA patient care and outcomes.

Related Experiment Videos